Botulinum toxin type A products are not interchangeable: a review of the evidence
Mitchell F Brin,1,2 Charmaine James,3 John Maltman1 1Allergan, Inc., Irvine, CA, USA; 2Department of Neurology, University of California, Irvine, CA, USA; 3Allergan, Marlow, UKAbstract: Botulinum toxin type A (BoNTA) products are injectable biologic medications derived from Clostridium botulinum ba...
Guardado en:
Autores principales: | Brin MF, James C, Maltman J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/171a3c9732204c7aa009be13e0a757e6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Botulinum toxin type A in the treatment of patients with cervical dystonia
por: Allison Brashear
Publicado: (2008) -
Cosmetic use of botulinum toxin type A in the elderly
por: Christine M Cheng
Publicado: (2007) -
Review of botulinum toxin type A for the prophylactic treatment of chronic daily headache
por: Stefan Evers
Publicado: (2007) -
Reviews of botulinum toxin products in aesthetic use must be accurate, clear and avoid speculation
por: Pickett A
Publicado: (2013) -
Efficacy of botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia previously treated with botulinum toxin type A: A post-marketing observational study in Japan
por: Ryuji Kaji, et al.
Publicado: (2021)